2021 American Transplant Congress Archives - Page 2 of 139

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

Harnessing Innate Lymphoid Cells to Prevent Graft-versus Host Disease

K. T. Reid¹, S. Q. Crome²
Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? A Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data

H. Sharma¹, A. Sharma²
Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data

H. Sharma¹, A. Sharma²
Health-related Quality of Life (HRQoL) in Patients on Dialysis and Kidney Transplant Recipients – Experience with the PROMIS Global-10 Survey

G. Chawla, W. Hajjar, M. Dastgheib, N. Yanga, G. Ahmadzadeh, N. El-Dassouki, A. Shahreza, N. Al Kaabi, N. Edwards, I. Mucsi
Healthcare Disparities Amongst Dialysis Patients in North Carolina: Decreased Access to Transplant in Lowest Health Rank Counties

D. Leto¹, W. Irish², C. Haisch², B. Tuttle², D. Leeser²
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation

H. Fernandez, A. Wall, A. Gupta, E. Martinez, J. Bayer, G. McKenna, N. Onaca, R. Ruiz, C. Spak, G. Testa
Hepatic Ferroptosis in Cold Stress and Warm Ischemia-reperfusion: A Novel Therapeutic Target in Liver Transplantation

H. Kojima¹, H. Hirao¹, K. Kadono¹, T. Ito¹, K. J. Dery¹, S. Kageyama², K. Nakamura³, F. M. Kaldas¹, D. G. Farmer¹, J. W. Kupiec-Weglinski¹
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience

M. Carter¹, M. Fitzmaurice², S. Yeddula², A. Singh², S. Nagai², S. Jafri²
Hepatocyte SIRT1 Suppresses Atf4-mediated Apoptosis Triggered by Cold Stress in Mouse and Human Liver Transplantation

K. Kadono¹, H. Hirao¹, H. Kojima¹, K. J. Dery¹, J. Aziz¹, X. Li², J. W. Kupiec-Weglinski¹
Hepatoportoenterostomy versus Primary Liver Transplantation for Biliary Atresia: A Review of the National Experience

D. Yoeli¹, R. A. Choudhury¹, S. S. Sundaram², C. L. Mack², J. P. Roach³, F. M. Karrer⁴, M. E. Wachs¹, M. A. Adams¹
High and Low Frequency Domino Liver Transplantation Centers Demonstrate Similar Outcomes

J. Panichella, H. Resweber, H. Curtis, K. Nguyen, A. Di Carlo, S. Karhadkar
High Degree of Center Variation in Simultaneous Heart Kidney Transplant: Opportunities for Standardization

B. I. Shaw¹, M. L. Samoylova¹, S. J. Kesseli¹, D. Olaso², A. S. Barbas¹, D. L. Sudan¹, L. E. Boulware³, L. M. McElroy¹
High Donor-Derived Cell-Free DNA Levels Predict Development of De Novo HLA Donor-Specific Antibodies After Kidney Transplantation – Data from the ADMIRAL Study

G. Gupta¹, T. Alhamad², V. Bowers³, I. Moinuddin¹, S. Ghosh⁴, J. Zeng⁴, E. Stites⁵, A. Pai⁶, J. S. Bromberg⁷, S. Anand⁸
High Interest, Low Payoff: Understanding Opportunities for Intervention for Those Exploring but Not Pursuing Paired Kidney Donation

A. D. Waterman¹, E. H. Wood¹, A. Thomas²
High Levels of Donor-Derived Cell-Free DNA Predict EGFR Decline After Kidney Transplantation

T. Alhamad¹, V. Bowers², E. Stites³, S. Anand⁴, J. S. Bromberg⁵, H. Murad¹, G. Gupta⁶, I. Moinuddin⁶, L. Bu⁷, S. Ghosh⁸, J. Zeng⁸, A. Pai⁹
High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test

C. E. Kuschner¹, Z. Brune², L. B. Becker¹, L. Teperman¹
Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II

M. Béland, S. De Serres
Higher Number of Tacrolimus Dose Adjustments and Trough Level Measurements in Kidney Transplant Recipients with CYP3A5*1 Alleles

K. Reininger¹, G. Onyeaghala², T. Anderson-Haag¹, B. Wu², W. Guan², C. R. Dorr², R. Remmel², R. Mannon³, A. Matas², W. Oetting², A. Israni¹, P. Stahler¹, P. Jacobson²
Highly Sensitized Simultaneous Liver-kidney Transplant Recipients Show a Reduction in Panel Reactive Antibodies and No Kidney Rejection 1-year Post-transplant

M. Moaddab, J. V. Nolte Fong, C. M. Mobley, A. Saharia, M. J. Hobeika, R. McMillan, S. G. Yi, R. J. Knight, A. Gaber, R. Ghobrial
HLA Allele Association with Recurrent Iga Nephropathy After Kidney Transplantation

O. Alzahabi, M. Merzkani, H. Murad, A. Java, R. Delos Santos, T. Alhamad, A. Malone
Hla Antigens and Recurrence of Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplantation

B. I. Shaw¹, A. Ochoa², C. Chan², R. A. Gbadegesin³, A. M. Jackson¹, E. T. Chambers³
HLA Haplotype Frequency and Racial Disparities in Access to Transplant Among Highly Sensitized Kidney Transplant Candidates

L. Gragert¹, M. Kadatz², D. Chang², H. Gebel³, D. Stewart⁴, E. Kransdorf⁵, S. Brar², S. Vaishnav², J. Gill², J. Lan²
HLA I Antibody-Activated Endothelium Polarized M2-Like Macrophages with Increased Efferocytic and Phagocytic Capacity

J. Nevarez-Mejia¹, X. Wei¹, N. M. Valenzuela¹, M. Rossetti¹, H. Pickering¹, G. A. Fishbein¹, A. Mulder², E. F. Reed¹
HLA Mismatching and Subclinical Inflammation: An Association to be Considered in Kidney Transplant Patients with Low Immunological Risk

T. Vazquez-Sanchez¹, J. Alonso-Titos¹, P. Ruiz-Esteban¹, A. Caballero², M. Leon³, V. Lopez¹, E. Sola¹, D. Hernández¹
Hla-dq Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation and Acute Cellular Rejection After Living Donor Liver Transplantation

K. Ono, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, N. Tanimine, S. Akimoto, Y. Imaoka, K. Sato, H. Yamane, N. Tsukiyama, R. Ide, T. Mochizuki, H. Ohdan
hlaR,” a Simplified Interface for the HLA Matchmaker Tool

A. Johnson¹, J. Zhang¹, H. Gebel², C. Larsen¹
Home-based Liver Frailty Intervention (lift) in Liver Transplant Candidates: A Pilot Study

A. J. Thuluvath¹, K. Belfanti¹, S. Morrissey¹, O. Siddiqui¹, J. Peipert¹, A. Daud¹, J. Levitsky¹, T. Bogg², A. Flores¹, D. P. Ladner¹
Hospital-Level Metrics and Interventions to Increase Deceased Organ Donation: A Systematic Review

M. Castillo-Angeles¹, G. Li², P. Bain³, A. Salim¹, J. T. Adler¹
Hospitalization in the First Year After Kidney Transplantation: Analyses to Identify Common Predictors of Risk Across Recipient Sensitization Groups

A. Santos, E. Bueno, M. A. Leghrouz
How Long is the Wait Worthwhile: Cost-Effectiveness of Accepting a Kidney from a Donor with Apolipoprotein L1 High-Risk Genotype

K. Lentine¹, D. Brennan², M. Wang³, M. Schnitzler⁴, H. Xiao⁴, D. Axelrod⁵, J. Snyder⁶, K. Lentine⁴
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?

F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
HTFPI.hCD47 and Adhesion Inhibition in GTKO.hCD46 Pig Lung Xenograft Injury

S. Miura¹, L. Burdorf¹, Z. Habibabady¹, A. Dandro², M. Connolly¹, S. Pratts¹, C. Phelps², W. Eyestone², D. Ayares², A. Azimzadeh¹, R. Pierson III¹
Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients

S. Parajuli, D. Kaufman, B. Welch, H. Sollinger, D. Mandelbrot, J. Odorico
Human Liver-derived Mesenchymal Stromal Cells (MSC) are Superior Inhibitors of Natural Killer Cells Compared to Bone Marrow or Adipose Tissue-derived MSC

F. Yigitbilek, M. J. Hansen, W. D. Park, M. D. Stegall, T. Taner
Hypercholesterolemia and Donor Age Impaired Capillary Vegf and Nitric Oxide (no) Expression and in Turn Decrease Both Microvascular Density and Tubule Villin Expression in Renal Allografts, Resulting in Poor Graft Survival

B. Ozdemir¹, E. Akcay¹, A. Ok Atilgan¹, M. Haberal²
Hypoperfusion Warm Ischaemia Time in Renal Transplants from Donors After Circulatory Death

I. D. Kostakis¹, T. Kassimatis¹, C. Flach², N. Karydis¹, N. Kessaris¹, I. Loukopoulos¹
Hypothermic Oxygenated Machine Perfusion Protects Against Cholangiocyte and Hepatocyte Injury and Mitigates Inflammation vs Static Cold Storage: Preliminary Results from a Single Center

G. Panayotova, F. Paterno, M. McCarty, G. Dikdan, S. Simonishvili, Y. Qin, L. Brown, A. Amin, K. E. Lunsford, J. V. Guarrera
Hypoxia Inducible Factor 1á (HIF-1á) Regulates Carcinoembryonic Antigen-related Cell Adhesion Molecule-1 (CEACAM1) Splice Isoforms to Protect Against Ischemic Injury in Mouse and Human Liver Transplantation

K. J. Dery, H. Kojima, K. Kadono, H. Hirao, J. W. Kupiec-Weglinski